1. Home
  2. RCKT vs API Comparison

RCKT vs API Comparison

Compare RCKT & API Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCKT
  • API
  • Stock Information
  • Founded
  • RCKT 1999
  • API 2013
  • Country
  • RCKT United States
  • API United States
  • Employees
  • RCKT N/A
  • API N/A
  • Industry
  • RCKT Biotechnology: Pharmaceutical Preparations
  • API Computer Software: Prepackaged Software
  • Sector
  • RCKT Health Care
  • API Technology
  • Exchange
  • RCKT Nasdaq
  • API Nasdaq
  • Market Cap
  • RCKT 328.6M
  • API 343.2M
  • IPO Year
  • RCKT N/A
  • API 2020
  • Fundamental
  • Price
  • RCKT $3.28
  • API $3.45
  • Analyst Decision
  • RCKT Buy
  • API Strong Buy
  • Analyst Count
  • RCKT 13
  • API 1
  • Target Price
  • RCKT $12.96
  • API $6.00
  • AVG Volume (30 Days)
  • RCKT 6.0M
  • API 508.9K
  • Earning Date
  • RCKT 08-07-2025
  • API 08-18-2025
  • Dividend Yield
  • RCKT N/A
  • API N/A
  • EPS Growth
  • RCKT N/A
  • API N/A
  • EPS
  • RCKT N/A
  • API N/A
  • Revenue
  • RCKT N/A
  • API $133,554,000.00
  • Revenue This Year
  • RCKT N/A
  • API $7.20
  • Revenue Next Year
  • RCKT $108.43
  • API $11.26
  • P/E Ratio
  • RCKT N/A
  • API N/A
  • Revenue Growth
  • RCKT N/A
  • API N/A
  • 52 Week Low
  • RCKT $2.19
  • API $1.78
  • 52 Week High
  • RCKT $22.01
  • API $6.99
  • Technical
  • Relative Strength Index (RSI)
  • RCKT 51.17
  • API 40.21
  • Support Level
  • RCKT $2.88
  • API $3.48
  • Resistance Level
  • RCKT $3.74
  • API $3.67
  • Average True Range (ATR)
  • RCKT 0.27
  • API 0.19
  • MACD
  • RCKT 0.02
  • API -0.02
  • Stochastic Oscillator
  • RCKT 35.43
  • API 10.17

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.

About API Agora Inc.

Agora Inc provides real-time communication solutions. The company offers real-time video calling, voice calling, live audio and video streaming, recording, and real-time messaging. It serves the gaming, retail, and education industries. The company operates in the People's Republic of China and the United States of America and the majority of its revenue is derived from the People's Republic of China.

Share on Social Networks: